413 related articles for article (PubMed ID: 16205765)
1. Is sentinel node status predictive of overall survival in patients with melanoma?
Carlson GW
Nat Clin Pract Oncol; 2005 Oct; 2(10):494-5. PubMed ID: 16205765
[No Abstract] [Full Text] [Related]
2. Sentinel lymph node biopsy for the T1 (thin) melanoma: is it necessary?
Nahabedian MY; Tufaro AP; Manson PN
Ann Plast Surg; 2003 Jun; 50(6):601-6. PubMed ID: 12783009
[TBL] [Abstract][Full Text] [Related]
3. Highly sensitive multivariable assay detection of melanocytic differentiation antigens and angiogenesis biomarkers in sentinel lymph nodes with melanoma micrometastases.
Vitoux D; Mourah S; Kerob D; Verola O; Basset-Seguin N; Baccard M; Schartz N; Ollivaud L; Archimbaud A; Servant JM; Revol M; Toubert ME; Podgorniak MP; Plassa F; Porcher R; Lebbé C
Arch Dermatol; 2009 Oct; 145(10):1105-13. PubMed ID: 19841396
[TBL] [Abstract][Full Text] [Related]
4. The role of sentinel lymph node biopsy in the management of thin melanoma.
Wong SL
Am J Surg; 2005 Aug; 190(2):196-9. PubMed ID: 16023430
[TBL] [Abstract][Full Text] [Related]
5. Predictive factors for false negative sentinel lymph node in melanoma patients.
Panasiti V; Devirgiliis V; Curzio M; Roberti V; Gobbi S; Rossi M; Bottoni U; Clerico R; Scuderi N; Calvieri S
Dermatol Surg; 2010 Oct; 36(10):1521-8. PubMed ID: 20698871
[TBL] [Abstract][Full Text] [Related]
6. Sentinel-lymph-node biopsy (SLNB) for melanoma is not complication-free.
Wasserberg N; Tulchinsky H; Schachter J; Feinmesser M; Gutman H
Eur J Surg Oncol; 2004 Oct; 30(8):851-6. PubMed ID: 15336731
[TBL] [Abstract][Full Text] [Related]
7. Factors predictive of nonsentinel lymph node involvement and clinical outcome in melanoma patients with metastatic sentinel lymph node.
Rossi CR; De Salvo GL; Bonandini E; Mocellin S; Foletto M; Pasquali S; Pilati P; Lise M; Nitti D; Rizzo E; Montesco MC
Ann Surg Oncol; 2008 Apr; 15(4):1202-10. PubMed ID: 18165880
[TBL] [Abstract][Full Text] [Related]
8. Sentinel lymph node biopsy in cutaneous melanoma: a case-control study.
Koskivuo I; Talve L; Vihinen P; Mäki M; Vahlberg T; Suominen E
Ann Surg Oncol; 2007 Dec; 14(12):3566-74. PubMed ID: 17924169
[TBL] [Abstract][Full Text] [Related]
9. Sentinel lymph node biopsy in thick malignant melanoma: a 10-year single unit experience.
Fairbairn NG; Orfaniotis G; Butterworth M
J Plast Reconstr Aesthet Surg; 2012 Oct; 65(10):1396-402. PubMed ID: 22552263
[TBL] [Abstract][Full Text] [Related]
10. Sentinel lymph node biopsy in cutaneous melanoma: outcome after 5-years follow-up.
Cuchet E; Pinel N; Corcella D; Vuillez JP; Lebeau J; Moutet F; Colonna M; Leccia MT
Eur J Dermatol; 2007; 17(5):387-91. PubMed ID: 17673381
[TBL] [Abstract][Full Text] [Related]
11. Unusual variants of malignant melanoma.
Barnhill RL; Gupta K
Clin Dermatol; 2009; 27(6):564-87. PubMed ID: 19880044
[TBL] [Abstract][Full Text] [Related]
12. Clinical and histopathological risk factors to predict sentinel lymph node positivity, disease-free and overall survival in clinical stages I-II AJCC skin melanoma: outcome analysis from a single-institution prospectively collected database.
Mandalà M; Imberti GL; Piazzalunga D; Belfiglio M; Labianca R; Barberis M; Marchesi L; Poletti P; Bonomi L; Novellino L; Di Biagio K; Milesi A; Guerra U; Tondini C
Eur J Cancer; 2009 Sep; 45(14):2537-45. PubMed ID: 19553103
[TBL] [Abstract][Full Text] [Related]
13. Sentinel node biopsy in melanoma delays recurrence but does not change melanoma-related survival: a retrospective analysis of 673 patients.
Gutzmer R; Al Ghazal M; Geerlings H; Kapp A
Br J Dermatol; 2005 Dec; 153(6):1137-41. PubMed ID: 16307648
[TBL] [Abstract][Full Text] [Related]
14. Determinants of unfavorable presentation of primary cutaneous melanoma.
Fallah M; Kharazmi E; Thomsen H; Sundquist J; Hemminki K
J Am Acad Dermatol; 2011 Jul; 65(1):e5-6. PubMed ID: 21679807
[No Abstract] [Full Text] [Related]
15. The role of microsatellites as a prognostic factor in primary malignant melanoma.
Shaikh L; Sagebiel RW; Ferreira CM; Nosrati M; Miller JR; Kashani-Sabet M
Arch Dermatol; 2005 Jun; 141(6):739-42. PubMed ID: 15967920
[TBL] [Abstract][Full Text] [Related]
16. Prognostic significance of extent of ulceration in primary cutaneous melanoma.
Grande Sarpa H; Reinke K; Shaikh L; Leong SP; Miller JR; Sagebiel RW; Kashani-Sabet M
Am J Surg Pathol; 2006 Nov; 30(11):1396-400. PubMed ID: 17063079
[TBL] [Abstract][Full Text] [Related]
17. Five years of sentinel node biopsy for melanoma: the St George's Melanoma Unit experience.
Topping A; Dewar D; Rose V; Cavale N; Allen R; Cook M; Powell B
Br J Plast Surg; 2004 Mar; 57(2):97-104. PubMed ID: 15037163
[TBL] [Abstract][Full Text] [Related]
18. Outcome of thick (> 4 mm) node-negative melanomas.
Zippel DB; Shapira R; Kuchuk I; Goitein D; Winkler E; Papa MZ; Schachter J
Isr Med Assoc J; 2009 Nov; 11(11):669-72. PubMed ID: 20108553
[TBL] [Abstract][Full Text] [Related]
19. Long-term follow-up reveals that ulceration and sentinel lymph node status are the strongest predictors for survival in patients with primary cutaneous melanoma.
de Vries M; Speijers MJ; Bastiaannet E; Plukker JT; Brouwers AH; van Ginkel RJ; Suurmeijer AJ; Hoekstra HJ
Eur J Surg Oncol; 2011 Aug; 37(8):681-7. PubMed ID: 21636244
[TBL] [Abstract][Full Text] [Related]
20. Size of sentinel node metastases predicts other nodal disease and survival in malignant melanoma.
Pearlman NW; McCarter MD; Frank M; Hurtubis C; Merkow RP; Franklin WA; Gonzalez R; Lewis K; Roaten JB; Robinson WA
Am J Surg; 2006 Dec; 192(6):878-81. PubMed ID: 17161112
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
